Concepedia

Lisa Drew

LD

40

Publications

3.9K

Citations

26

H-Index

1994

Active since

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

Harvard University

University of York

Columbia University

Lisa Drew is an author at AstraZeneca (United States) specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1994–2024

40

Publications

40

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

Ryohei Katayama, Alice T. Shaw, Tahsin Khan et al. · Science Translational Medicine · 2012 · 1.3K citations

Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma

Clara Montagut, Sreenath V. Sharma, Toshi Shioda et al. · Cancer Research · 2008 · 502 citations · Full text

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

Ultan McDermott, Sreenath V. Sharma, Lori Dowell et al. · Proceedings of the National Academy of Sciences · 2007 · 355 citations · Full text

, , +18

CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype

Juliana Candido, Jennifer P. Morton, Peter J. Bailey et al. · Cell Reports · 2018 · 215 citations · Full text

EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex

Jessie Hao-Ru Hsu, Timothy Rasmusson, James Robinson et al. · Cell chemical biology · 2019 · 192 citations · Full text

, ,

Rows per page

1–5 of 40